Kamada KMDA
NASDAQ KMDA
$7.69 +0.46 (+6.36%)
At close: Nov 9, 2026 · 4:00 PM EST

Kamada (KMDA) Return on Invested Capital [ROIC] (2018 - 2026)

Updated

Kamada (KMDA) recorded Return on Invested Capital [ROIC] of 10.20% in the quarter ended Jun 30, 2026, up 0.72 percentage points from 9.48% a year earlier and up 0.95 percentage points from the prior quarter.

Analysis

Kamada (KMDA) Return on Invested Capital [ROIC] (2018 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Kamada reported Return on Invested Capital [ROIC] of 9.56%, up 1.98 percentage points from the prior year.

  • Annual Return on Invested Capital [ROIC] has increased for four straight years, though with a five-year change of -1.72 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Return on Invested Capital [ROIC] came in at 7.59% in the year ended Dec 31, 2024 (+3.30 pp), 4.29% in the year ended Dec 31, 2023 (+2.11 pp), 2.18% in the year ended Dec 31, 2022 (+2.55 pp) and -0.37% in the year ended Dec 31, 2021 (-11.66 pp).
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Return on Invested Capital [ROIC] since the quarter ended Sep 30, 2020.
  • On a year-over-year basis, Return on Invested Capital [ROIC] has increased for 14 consecutive quarters, with an average year-over-year change of +2.37 percentage points over the last eight quarters.
  • The year-over-year gain in Return on Invested Capital [ROIC] has ranged between 0.31 percentage points (the quarter ended Mar 31, 2026) and 10.10 percentage points (the quarter ended Jun 30, 2023) over the last five years.
  • Per Business Quant, the preceding three quarters came in at 9.25% (quarter ended Mar 31, 2026), 9.46% (quarter ended Dec 31, 2025) and 10.18% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 38.16%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 17.57%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 24.28%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 2.88%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 24.11%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 15.60%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -6.11%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 12.34%
10 Kamada 441.57 Mn 150.63 Mn 22.47 Mn 10.20%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.20%
Mar 31, 2026 8.66%
Dec 31, 2025 8.86%
Sep 30, 2025 10.18%
Jun 30, 2025 9.48%
Mar 31, 2025 8.32%
Dec 31, 2024 6.39%
Sep 30, 2024 6.72%
Jun 30, 2024 6.37%
Mar 31, 2024 5.23%
Dec 31, 2023 3.82%
Sep 30, 2023 4.66%
Jun 30, 2023 4.69%
Mar 31, 2023 2.48%
Dec 31, 2022 4.36%
Sep 30, 2022 -16.37%
Jun 30, 2022 -5.73%
Mar 31, 2022 -1.44%
Dec 31, 2020 9.98%
Sep 30, 2020 11.96%
API Access

Kamada Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=KMDA&period=max&api_key=YOUR_API_KEY